Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

NB‐UVB vs PUVA

Patient‐reported changes in symptoms ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

NB‐UVB vs PUVA

Investigator Global Assessment · atopic eczema

It is very uncertain whether summary of findings table ‐ NB‐UVB changes investigator Global Assessment compared with PUVA (very low certainty).

1 finding from 1 review

NB‐UVB vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review

UVA1 vs PUVA

Patient‐reported changes in symptoms ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Investigator Global Assessment ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

NB‐UVB vs placebo

Patient‐reported changes in symptoms · atopic eczema

Summary of findings table ‐ NB‐UVB may leads to higher patient‐reported changes in symptoms compared with placebo (low certainty).

1 finding from 1 review

UVA1 vs PUVA

Withdrawals due to adverse events not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

NB‐UVB vs placebo

Investigator Global Assessment · atopic eczema

Summary of findings table ‐ NB‐UVB may leads to higher investigator Global Assessment (short‐term) compared with placebo (low certainty).

1 finding from 1 review

NB‐UVB vs placebo

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

NB‐UVB vs UVA1

Investigator Global Assessment ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review